{
    "prefix": "Approach the following multiple choice question the way a medical researcher would. ",
    "problem_prompt": "Approach the following multiple choice question the way a medical researcher would. Patient on treatment on carbidopa + levodopa for 10 yrs now has weaning off effect. What should be added to restore action -\n1: Tolcapone\n2: Amantadine\n3: Rasagiline\n4: Benzhexol",
    "solution": 1,
    "gpt_response": "As a medical researcher, I would approach this question by considering the mechanism of action of each potential treatment option in order to determine which medication would be most likely to restore the action of carbidopa + levodopa in the patient experiencing weaning off effects.\n\nTolcapone is a COMT inhibitor that can help to prolong the effects of levodopa by inhibiting its breakdown in the body. Amantadine is an NMDA receptor antagonist that can help to reduce symptoms of dyskinesia in patients with Parkinson's disease. Rasagiline is a MAO-B inhibitor that can help to increase levels of dopamine in the brain by inhibiting its breakdown. Benzhexol is an anticholinergic medication that can help to reduce tremors and muscle stiffness in patients with Parkinson's disease.\n\nBased on these mechanisms of action, the most appropriate choice for restoring the action of carbidopa + levodopa in a patient experiencing weaning off effects would be option 1: Tolcapone. By inhibiting the breakdown of levodopa, tolcapone can help to prolong the effects of the medication and improve symptom control in the patient. Amantadine may also be a useful adjunct therapy in some cases, but tolcapone would be the most direct choice for restoring the action of carbidopa + levodopa in this scenario.",
    "solution_prompt": "The following is a response to a question, with options 1, 2, 3, 4. Yes or no, is the final solution obtained in the following response 1?: As a medical researcher, I would approach this question by considering the mechanism of action of each potential treatment option in order to determine which medication would be most likely to restore the action of carbidopa + levodopa in the patient experiencing weaning off effects.\n\nTolcapone is a COMT inhibitor that can help to prolong the effects of levodopa by inhibiting its breakdown in the body. Amantadine is an NMDA receptor antagonist that can help to reduce symptoms of dyskinesia in patients with Parkinson's disease. Rasagiline is a MAO-B inhibitor that can help to increase levels of dopamine in the brain by inhibiting its breakdown. Benzhexol is an anticholinergic medication that can help to reduce tremors and muscle stiffness in patients with Parkinson's disease.\n\nBased on these mechanisms of action, the most appropriate choice for restoring the action of carbidopa + levodopa in a patient experiencing weaning off effects would be option 1: Tolcapone. By inhibiting the breakdown of levodopa, tolcapone can help to prolong the effects of the medication and improve symptom control in the patient. Amantadine may also be a useful adjunct therapy in some cases, but tolcapone would be the most direct choice for restoring the action of carbidopa + levodopa in this scenario.",
    "gpt_response_correct_incorrect": "Yes",
    "attempts": 3,
    "yes_no": "yes",
    "gpt_response_difficulty": "2",
    "difficulty_value": "2"
}